123 related articles for article (PubMed ID: 22264592)
41. Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria.
Kothur K; Singh S; Sharma Y; Mittal BR
J Cardiol; 2007 Nov; 50(5):299-307. PubMed ID: 18044459
[TBL] [Abstract][Full Text] [Related]
42. Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.
Luo L; Feng S; Wu Y; Su Y; Jing F; Yi Q
Pediatr Infect Dis J; 2019 Jan; 38(1):89-94. PubMed ID: 29601451
[TBL] [Abstract][Full Text] [Related]
43. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?
McCrindle BW; McIntyre S; Kim C; Lin T; Adeli K
J Pediatr; 2007 Sep; 151(3):244-8, 248.e1. PubMed ID: 17719931
[TBL] [Abstract][Full Text] [Related]
44. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease.
Li G; Wang T; Li J; Chen P; Jia P; Zhao J; Duan Y; Liu D; Xu X; Liu B
Clin Chim Acta; 2020 Aug; 507():264-270. PubMed ID: 32387635
[TBL] [Abstract][Full Text] [Related]
45. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions.
Furui J; Ishii M; Ikeda H; Muta H; Egami K; Sugahara Y; Himeno W; Akagi T; Kato H; Matsuishi T
Acta Paediatr; 2002; 91(11):1183-8. PubMed ID: 12463316
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease.
Tacke CE; Romeih S; Kuipers IM; Spijkerboer AM; Groenink M; Kuijpers TW
Circ Cardiovasc Imaging; 2013 Jan; 6(1):67-73. PubMed ID: 23197079
[TBL] [Abstract][Full Text] [Related]
47. The significance of early subtle coronary arterial lesions on echocardiogram in Kawasaki disease.
Chang JS; Tsai CH; Wu MH; Wang JK
Acta Paediatr Taiwan; 1999; 40(2):101-6. PubMed ID: 10910596
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of Kawasaki Disease: A Single-Center Experience.
Uysal F; Bostan OM; Celebi S; Uysal B; Hamitoglu S; Cil E
Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
[TBL] [Abstract][Full Text] [Related]
49. The vascular function of the long-term coronary artery after Kawasaki disease--evaluation by intracoronary injection of acetylcholine.
Yamakawa R
Kurume Med J; 1997; 44(1):7-14. PubMed ID: 9154757
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.
Jujo T; Sakao S; Ishibashi-Ueda H; Ishida K; Naito A; Sugiura T; Shigeta A; Tanabe N; Masuda M; Tatsumi K
PLoS One; 2015; 10(8):e0133167. PubMed ID: 26252755
[TBL] [Abstract][Full Text] [Related]
51. Modulating effects of mannose binding lectin genotype on arterial stiffness in children after Kawasaki disease.
Cheung YF; Ho MH; Ip WK; Fok SF; Yung TC; Lau YL
Pediatr Res; 2004 Oct; 56(4):591-6. PubMed ID: 15295097
[TBL] [Abstract][Full Text] [Related]
52. Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions.
Sheu JJ; Lin YJ; Chang JS; Wan L; Chen SY; Huang YC; Chan C; Chiu IW; Tsai FJ
Int J Immunogenet; 2010 Dec; 37(6):487-92. PubMed ID: 20618517
[TBL] [Abstract][Full Text] [Related]
53. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.
Furuno K; Takada H; Yamamoto K; Ikeda K; Ohno T; Khajoee V; Mizuno Y; Hara T
J Pediatr; 2007 Aug; 151(2):155-60, 160.e1. PubMed ID: 17643768
[TBL] [Abstract][Full Text] [Related]
54. The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in Kawasaki disease.
Huang T; Peng Q; Zhang Y; Zhu Z; Fan X
Clin Exp Med; 2024 Jan; 24(1):4. PubMed ID: 38231301
[TBL] [Abstract][Full Text] [Related]
55. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
[TBL] [Abstract][Full Text] [Related]
56. Pulse Wave Velocity in Kawasaki Disease.
Iwazu Y; Minami T; Kotani K
Angiology; 2017 Mar; 68(3):189-195. PubMed ID: 27225700
[TBL] [Abstract][Full Text] [Related]
57. Arterial stiffness in preeclamptic and chronic hypertensive pregnancies.
Tihtonen KM; Kööbi T; Uotila JT
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):180-6. PubMed ID: 16530917
[TBL] [Abstract][Full Text] [Related]
58. Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis.
Kim JJ; Park YM; Yoon D; Lee KY; Seob Song M; Doo Lee H; Kim KJ; Park IS; Nam HK; Weon Yun S; Ki Han M; Mi Hong Y; Young Jang G; Lee JK;
J Hum Genet; 2013 Aug; 58(8):521-5. PubMed ID: 23677057
[TBL] [Abstract][Full Text] [Related]
59. Coronary artery fistula associated with Kawasaki disease.
Liang CD; Kuo HC; Yang KD; Wang CL; Ko SF
Am Heart J; 2009 Mar; 157(3):584-8. PubMed ID: 19249434
[TBL] [Abstract][Full Text] [Related]
60. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
